Acasti Pharma Inc. Discusses Year-End Results and Clinical Development Progress with The Stock Day Podcast

<div>The Stock Day Podcast welcomed Acasti Pharma Inc. (ACST)(“the Company”), a specialty pharma company with drug delivery technologies and novel drug candidates addressing rare and orphan diseases. CEO of the Company, Jan D’Alvise, joined Stock Day host Sever Copley. </div>